$92.34 +0.24 (0.26%)

VanEck Pharmaceutical ETF (PPH)

Dividend Yield 2.1%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
October 6, 2025$0.392025-10-012025-10-01
July 7, 2025$0.612025-07-012025-07-01
April 4, 2025$0.522025-04-012025-04-01
December 30, 2024$0.412024-12-272024-12-27
October 4, 2024$0.412024-10-012024-10-01

Dividends Summary

Company News

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
The Motley Fool • Matthew Benjamin • October 13, 2025

Pharmaceutical stocks experienced significant gains after the Trump administration delayed potential drug import tariffs, with major drugmakers striking deals to invest in U.S. manufacturing and avoid potential 100% tariffs.

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Benzinga • Rishabh Mishra • September 29, 2025

Economist Justin Wolfers warns that proposed 100% tariffs on foreign pharmaceuticals will likely be passed onto American patients and insurers, particularly for patented brand-name drugs with inelastic demand.

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks Investment Research • Zacks Equity Research • June 28, 2024

Smart Beta ETF report for PJP

Technology Leader Pushpay Announces Executive Leadership Hire, Welcomes Burt Y. Chao as Chief Financial Officer
GlobeNewswire Inc. • Pushpay • September 14, 2023

Chao will lead Pushpay’s finance and accounting teams, optimizing financial performance for the now privately held SaaS company Chao will lead Pushpay’s finance and accounting teams, optimizing financial performance for the now privately held SaaS company

Schumer provides 'rock-solid evidence' that Democrats will push forward with partisan tax and spending bill, analyst says
MarketWatch • MarketWatch • July 6, 2022

Democrats have long hoped to coalesce around a plan to roll back some of Donald Trump's tax cuts for wealthy individuals and corporations to pay for new spending on healthcare and the fight against climate change, and it appears that plan is finally taking shape.